TOP TIERMARKET NEWSWIRE
News & sentiment

DARE BIOSCIENCE INC Equity (DARE) — News & AI sentiment

DARE BIOSCIENCE INC Equity (DARE) news roundup. 1 story in the past week, 7 over 30 days. Average 30-day sentiment is 55/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 63/100
30d stories
7
avg sentiment 55/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

DARE news in the last 24 hours, 7 days, 30 days and 90 days

How much DARE coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowDARE storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days163/100DARE headlines →
Last 30 days755/100DARE headlines →
Last 90 days4053.2/100DARE headlines →

Latest stories on DARE

2d ago
Oct 8
Oct 8
Dare Bioscience, Inc. (DARE) files 8-K
SEC 8-K34 · bearishgeneral
Oct 2
Oct 1
Dare Bioscience, Inc. (DARE) files 8-K
SEC 8-K50 · neutralgeneral
Oct 1
Dare Bioscience stock rises after receiving HPV treatment patent
Investing.com Markets63 · neutralproduct/pr
Sep 28
Sep 28
Sep 28
Sep 28
Sep 14
Sep 14
Sep 11
Dare Bioscience, Inc. (DARE) files 8-K
SEC 8-K50 · neutralgeneral
Sep 11
Sep 11
Dare Bioscience, Inc. (DARE) files 8-K
SEC 8-K50 · neutralgeneral
Sep 9
Aug 31
Aug 27
Aug 26
Aug 26
Aug 26
Aug 25
Aug 25
Aug 24
Aug 20
Open DARE in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →